India is home to one of the world’s fastest-growing veterinary pharmaceutical industries — and if you’re a vet, distributor, farmer, or entrepreneur, choosing the right manufacturer can make or break your animal healthcare outcome.
The Indian veterinary medicine sector hit approximately USD 1.76 billion in 2026 and is on track to cross USD 4.2 billion by 2033, growing at a robust CAGR of 12.4%. Whether you’re sourcing antibiotics for your livestock, building a PCD franchise, or launching your own private-label veterinary brand, understanding who the best veterinary medicine manufacturers in India are — and what separates the good from the great — is your most important first step.
What Are Veterinary Medicine Manufacturers in India?
Veterinary medicine manufacturers in India are licensed pharmaceutical companies that research, develop, produce, and supply medicines, biological products, and health supplements specifically formulated for animals — including livestock (cattle, goats, sheep, pigs), poultry (broilers, layers), companion animals (dogs, cats), and aquaculture species.
These manufacturers operate under strict oversight from the Central Drugs Standard Control Organisation (CDSCO) and must comply with the Drugs and Cosmetics Act, 1940, along with WHO-GMP and Good Manufacturing Practice (GMP) standards. Their product portfolio spans everything from injectable antibiotics and boluses to feed supplements, vaccines, and herbal formulations.
Veterinary medicine manufacturers in India are CDSCO-regulated pharmaceutical companies that produce animal healthcare products including therapeutics, vaccines, nutritional supplements, and feed additives for livestock, poultry, and companion animals.
Why India Is a Global Hub for Veterinary Pharmaceuticals in 2026
India isn’t just the world’s pharmacy for humans — it’s rapidly becoming the world’s pharmacy for animals too. Here’s why:
India holds the world’s largest livestock population, with over 307.5 million bovine cattle and water buffalo as of 2025, according to the Foreign Agriculture Service. That’s an enormous, permanent domestic market for animal drug manufacturers.
Add to this:
- Pet dog ownership jumped from 12.6 million in 2014 to 33.6 million in 2023 and is projected to reach 51.5 million by 2028.
- Urban households already show 25% pet penetration, shifting demand toward premium multi-specialty pet care.
- Government programs like the Rashtriya Gokul Mission, National Animal Disease Control Programme (NADCP), and the Animal Husbandry Infrastructure Development Fund are pouring public investment into the sector.
- Indigenous vaccine development, especially post the lumpy skin disease outbreak, is reducing India’s import reliance and strengthening domestic supply chains.
The result: veterinary pharma manufacturers in India are operating in a sector with rare structural tailwinds — large livestock base, growing pet ownership, government support, and rising export demand all at once.
Latest Regulatory Update
CDSCO Issues Directive on Banned Antibiotics in Food Animals
On June 3, 2026, the Drugs Controller General of India (DCGI) issued a directive to all State and Union Territory Drug Controllers, following a rise in Indian shrimp export rejections by international buyers due to residues of chloramphenicol and nitrofuran — two classes of antibiotics banned from use in food-producing animals under a March 11, 2025 notification.
CDSCO has now directed states to:
- Enforce strict reconciliation of these drugs sold to licensed manufacturers only
- Take immediate regulatory action against violations under the Drugs and Cosmetics Act, 1940
- Submit time-bound compliance reports to CDSCO
Why this matters: If you’re a veterinary medicines manufacturer or supplier working with aquaculture or food animal sectors, compliance with this directive is non-negotiable. Non-compliance risks product recalls, export bans, and licensing consequences. Trustworthy veterinary pharmaceutical manufacturers like Vetset Lifecare have always maintained ATO-compliant, WHO-GMP certified processes — and this regulatory tightening is making that certification more valuable than ever.
Types of Veterinary Medicine Manufacturers in India
India’s veterinary pharma ecosystem is diverse. Here’s a breakdown of the major categories of animal drug manufacturers:
1. Pharmaceutical (Therapeutic) Manufacturers
These companies focus on treatment-oriented products — antibiotics, anti-parasitics, anti-fungals, anti-inflammatory drugs, and injectables. They represent the largest segment and serve both livestock and companion animal markets.
2. Nutraceutical & Feed Supplement Manufacturers
Producing growth promoters, liver tonics, mineral mixtures, and vitamins, these manufacturers cater to commercial farmers looking to improve productivity and immunity without relying on therapeutic drugs.
3. Biological Manufacturers
Biological manufacturers produce vaccines, antitoxins, and immunomodulators. Post the lumpy skin disease crisis, this segment has seen the biggest government investment push in 2025–2026.
4. Herbal & Ayurvedic Veterinary Manufacturers
An emerging niche, these manufacturers produce plant-based formulations for deworming, liver support, and stress management — increasingly popular with organic farmers and export-oriented livestock farms.
5. Third-Party / Contract Manufacturers
These manufacturers offer white-label and private-label manufacturing services, allowing entrepreneurs, regional brands, and distributors to launch their own veterinary product lines without building a plant.
Comparison Table: Types of Veterinary Manufacturers in India
| Type | Key Products | Best For | Regulatory Requirement |
|---|---|---|---|
| Pharmaceutical | Antibiotics, injectables, boluses | Livestock treatment | WHO-GMP + CDSCO license |
| Nutraceutical | Vitamins, liver tonics, growth promoters | Farm productivity | GMP certification |
| Biological | Vaccines, serums | Disease prevention | CDSCO + DCGI approval |
| Herbal/Ayurvedic | Plant-based tonics, dewormers | Organic farming | GMP + AYUSH guidelines |
| Third-Party/Contract | White-label full portfolio | New brand launch | Must partner with GMP unit |
Key Products Offered by Veterinary Medicine Manufacturers in India
A full-service veterinary pharmaceutical manufacturer typically offers products across these categories:
For Livestock (Cattle, Buffalo, Goat, Sheep):
- Antibiotics and anti-infective injectables
- Calcium borogluconate injectables (for milk fever)
- Iron dextran injectables
- Vitamin B-complex and AD3E
- Liver tonics and digestive enzymes
- Anthelmintics (dewormers)
- Mineral and trace element supplements
- Boluses for controlled-release therapy
For Poultry:
- Antibiotics (water-soluble)
- Anticoccidials
- Electrolytes and stress relief products
- Growth promoters
- Enzyme feed additives
For Companion Animals:
- Multivitamin syrups
- Calcium supplements
- Skin and coat products
- Anti-parasitic spot-ons and oral tablets
- Nutritional powders
Companies like Vetset Lifecare (Ambala, Haryana), a WHO-GMP certified veterinary pharma company, cover this full spectrum — from injections and boluses to feed supplements — making them a one-stop partner for distributors and franchise seekers.
India’s Top Veterinary Manufacturing Hubs: Where Are They?
| Region | Why It Matters |
|---|---|
| Punjab & Haryana | Largest livestock density; strong distribution infrastructure; home to major manufacturers like Vetset Lifecare |
| Gujarat | Pharma manufacturing powerhouse; strong export orientation |
| Himachal Pradesh (Baddi-Nalagarh) | Tax-incentivized pharma belt; many large-scale manufacturers |
| Maharashtra | Advanced R&D and biotech infrastructure |
| Uttar Pradesh | Fastest-growing veterinary market; large cattle belt |
| Andhra Pradesh | Aquaculture-focused; growing animal drug manufacturing |
Benefits of Partnering with Indian Veterinary Medicine Manufacturers
Cost-Effective Without Compromising Quality
Indian veterinary drug manufacturers can produce high-quality medicines at 30–60% lower cost compared to their counterparts in Europe or the US — driven by lower labour costs, domestic raw material availability, and government incentives.
Global Quality Standards
Leading manufacturers in India follow WHO-GMP, ISO 9001:2015, and CDSCO certification frameworks. This makes Indian veterinary medicines exportable to Southeast Asia, Africa, the Middle East, and SAARC nations.
Massive Product Range
From single-molecule injectables to complex multi-ingredient feed supplements, Indian manufacturers offer one of the widest veterinary product portfolios in Asia.
Third-Party Manufacturing Flexibility
Entrepreneurs and regional distributors can launch their own veterinary brand through third-party manufacturing — without investing crores in plant setup. A GMP-certified manufacturer handles production; you handle branding and sales.
PCD Franchise Opportunities
India’s veterinary PCD (Propaganda Cum Distribution) franchise model is a proven low-investment business model. Partnering with an established veterinary pharma manufacturer gives you monopoly rights in your territory.
How to Choose the Right Veterinary Medicine Manufacturer in India
This is where most buyers and franchise seekers get it wrong. Price alone is never a good criterion. Here’s what actually matters:
1. Certifications and Compliance
Non-negotiable. Look for WHO-GMP, CDSCO drug manufacturing license, and — especially for food animal products post the June 2026 CDSCO directive — strict compliance with antibiotic use guidelines. A single contamination or compliance issue can shut down your distribution business.
2. Product Portfolio Depth
A manufacturer with 100+ products across injectables, oral liquids, boluses, powders, and feed supplements gives you the flexibility to grow your franchise or distribution business.
3. Cold Chain and Logistics
Biological products (vaccines, some injectables) require cold chain infrastructure. Verify your manufacturer has cold storage and temperature-controlled dispatch capability.
4. Labeling and Packaging Standards
CDSCO mandates specific labeling for veterinary drugs — species indication, withdrawal period (for food animals), dosage, batch number, and manufacturing/expiry dates. Verify compliance before you stock.
5. R&D and Innovation Track Record
In a market growing at 12.4% CAGR, manufacturers that invest in new formulations and biotech-based products will outpace commodity players.
6. Transparent Pricing and MRP Support
For franchise and distribution partners, the manufacturer’s Price List (PL), Maximum Retail Price (MRP) policy, and promotional input (visual aids, samples, doctor visit support) matter as much as product quality.
Business Opportunities with Veterinary Medicine Manufacturers in India
The veterinary pharma sector is one of the most underserved yet profitable sectors in Indian pharma. Here’s what’s available:
| Business Model | Investment Level | Potential |
|---|---|---|
| PCD Franchise | Low (₹50K–₹2L) | Monopoly territory rights; recurring income |
| Third-Party Manufacturing | Medium (₹2L–₹10L) | Own brand; full margin control |
| Distribution/Super Stockist | Medium-High | Region-level supply chain margins |
| Export Business | High | Global reach; SAARC, Africa, Middle East |
| Veterinary E-Commerce | Low-Medium | Digital-first; growing with telemedicine |
Why Vetset Lifecare Stands Out Among Veterinary Medicine Manufacturers in India
Headquartered in Ambala, Haryana — right at the heart of India’s northern livestock belt — Vetset Lifecare is a WHO-GMP certified veterinary pharma company that has built its reputation on three pillars:
Science-backed formulations. Every product in the Vetset Lifecare portfolio — from injectable antibiotics to boluses, feed supplements, and liver tonics — is developed following strict research and quality protocols.
ATO-compliant processes. With CDSCO’s regulatory environment tightening in 2025–2026, ATO compliance isn’t optional. Vetset Lifecare’s manufacturing infrastructure is designed around it.
Full-spectrum partnership model. Whether you’re a veterinarian sourcing medicines, a distributor looking to expand your portfolio, or an entrepreneur ready to launch your own veterinary brand through third-party manufacturing or PCD franchise, Vetset Lifecare offers structured partnership programmes with dedicated support.
Their product range covers injections, boluses, and feed supplements for livestock, poultry, and companion animals — making them one of the most versatile veterinary medicine suppliers in India for pan-India distribution.
Key Takeaways
- India’s veterinary medicine market is valued at approximately USD 1.76 billion in 2026 and growing at 8.6–12.4% CAGR through 2033
- India holds the world’s largest livestock population — over 307.5 million bovines — creating unmatched domestic demand
- WHO-GMP and CDSCO compliance are mandatory for all veterinary pharmaceutical manufacturers; regulatory enforcement is tightening in 2026
- CDSCO issued a critical June 2026 directive banning chloramphenicol and nitrofuran use in food-producing animals — non-compliant manufacturers risk license action
- Five types of veterinary manufacturers operate in India: pharmaceutical, nutraceutical, biological, herbal, and third-party contract manufacturers
- Punjab, Haryana, Gujarat, and Himachal Pradesh are India’s top veterinary pharma manufacturing hubs
- PCD franchise and third-party manufacturing are the two most accessible entry points for entrepreneurs in the veterinary pharma sector
- Choosing a WHO-GMP certified, ATO-compliant manufacturer like Vetset Lifecare minimises regulatory and quality risk for partners
FAQ Section
1. Who are the top veterinary medicine manufacturers in India?
India has several reputable veterinary pharmaceutical manufacturers, including WHO-GMP certified companies headquartered in pharma hubs like Ambala (Haryana), Baddi (Himachal Pradesh), Ahmedabad (Gujarat), and Pune (Maharashtra). Companies like Vetset Lifecare are recognised for their full-spectrum product range, regulatory compliance, and support for PCD franchise and third-party manufacturing partners across India.
2. What is the difference between veterinary pharmaceutical manufacturers and animal drug manufacturers?
The terms are often used interchangeably. Broadly, “veterinary pharmaceutical manufacturers” refers to companies producing therapeutic medicines, vaccines, and biological products for animals, while “animal drug manufacturers” is a wider term that includes nutraceutical and feed additive producers. In India, both are regulated under the Drugs and Cosmetics Act, 1940, and require CDSCO licensing.
3. Are Indian veterinary medicines WHO-GMP certified?
Many leading veterinary medicine manufacturers in India are WHO-GMP certified. This certification, granted by India’s drug regulatory authorities, confirms that the manufacturing facility meets WHO’s Good Manufacturing Practice standards for pharmaceutical production — covering facility hygiene, process validation, quality control, and documentation. Always verify certification before entering a supply or franchise agreement.
4. How can I start a veterinary PCD franchise in India?
To start a veterinary PCD franchise in India, identify a WHO-GMP certified veterinary pharma manufacturer that offers monopoly-based franchise rights. You will typically need a Drug License and GST registration. The manufacturer provides their product portfolio, price list, and promotional inputs; you handle sales and distribution in your designated territory. Investment typically ranges from ₹50,000 to ₹2 lakh for initial stock.
5. What products do veterinary medicine manufacturers in India produce?
Indian veterinary manufacturers produce antibiotics, anti-parasitic drugs, vitamins and mineral supplements, liver tonics, growth promoters, injectables (calcium borogluconate, iron dextran, B-complex), boluses, vaccines, feed additives, electrolytes, and herbal/Ayurvedic formulations — covering livestock, poultry, companion animals, and aquaculture.
6. What is third-party veterinary pharma manufacturing?
Third-party veterinary pharma manufacturing (also called contract manufacturing or private label manufacturing) is an arrangement where a brand owner or entrepreneur outsources production to a licensed, GMP-certified manufacturer. The manufacturer produces the product under the client’s brand name and label. This allows businesses to launch their own veterinary medicine brand without building a manufacturing facility.
7. What are the regulatory requirements for veterinary medicine manufacturers in India?
Veterinary medicine manufacturers in India must hold a valid drug manufacturing license issued by the State Licensing Authority (SLA), comply with the Drugs and Cosmetics Act, 1940, maintain WHO-GMP standards, obtain CDSCO approval for new veterinary drugs, and adhere to product-specific labeling regulations including species indication, dosage, batch number, and withdrawal period for food animals.
8. What is the June 2026 CDSCO directive on veterinary drugs?
On June 3, 2026, CDSCO directed all State and UT Drug Controllers to enforce the March 2025 ban on chloramphenicol and nitrofuran antibiotics in food-producing animals, following a surge in Indian shrimp export rejections by international markets. Manufacturers are required to sell these substances only to licensed bulk/formulation manufacturers for non-food animal purposes, with strict reconciliation. Non-compliant entities face action under the Drugs and Cosmetics Act, 1940.
9. Why is India growing so fast in veterinary pharma manufacturing?
India’s veterinary pharma sector is growing due to: the world’s largest livestock population (307.5 million bovines), rapidly rising pet ownership (33.6 million dogs in 2023; projected 51.5 million by 2028), government livestock health programmes (Rashtriya Gokul Mission, NADCP), cost-competitive manufacturing, WHO-GMP capable infrastructure, and growing export demand from SAARC, Africa, and Southeast Asian markets.
10. What should I look for when choosing a veterinary medicine supplier in India?
Key criteria include: WHO-GMP and CDSCO certification, breadth of product portfolio, compliance with current regulations (including the 2025–2026 antibiotic ban), cold chain infrastructure for biologicals, transparent pricing and MRP policy, third-party manufacturing or PCD franchise support, and a verifiable track record of quality and on-time delivery. Companies like Vetset Lifecare that are ATO-compliant and WHO-GMP certified offer a lower-risk partnership for distributors and franchise operators.
11. What is the market size of veterinary medicines in India in 2026?
The India veterinary healthcare market is estimated at approximately USD 1.76 billion in 2026 (Mordor Intelligence), growing from USD 1.62 billion in 2025, with projections ranging from USD 4.17 billion to USD 6.13 billion by 2033 depending on the scope of study. The veterinary medicine sub-sector specifically (pharmaceuticals, biologics, medicated feed additives) is expected to grow at a CAGR of 10–12.4% through 2033.
12. Can veterinary medicines manufactured in India be exported?
Yes. Many Indian veterinary pharmaceutical manufacturers export to Southeast Asia, Africa, the Middle East, and SAARC nations. India’s cost competitiveness, WHO-GMP certified facilities, and wide product range make it an attractive export source. However, exporters must comply with destination country registration requirements and cannot export products banned in India (such as chloramphenicol and nitrofuran for food animals, per the March 2025 CDSCO notification).